Rafferty Asset Management, LLC Immunovant, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 152,347 shares of IMVT stock, worth $4.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

152,347

Previous 140,698 8.28%

Holding current value

$4.19 Million

Previous $3.71 Million 12.84%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.51 - $27.51 $320,463 - $320,463	11,649 Added 8.28%	152,347 $4.19 Million
Q2 2024 Aug 13, 2024	SELL	$25.1 - $31.61 $3.73 Million - $4.7 Million	-148,687 Reduced 51.38%	140,698 $3.71 Million
Q1 2024 May 13, 2024	BUY	$30.27 - $43.79 $1.83 Million - $2.64 Million	60,298 Added 26.32%	289,385 $9.35 Million
Q4 2023 Feb 13, 2024	SELL	$31.31 - $44.19 $2.12 Million - $2.99 Million	-67,745 Reduced 22.82%	229,087 $9.65 Million
Q3 2023 Nov 13, 2023	BUY	$18.55 - $39.96 $838,664 - $1.81 Million	45,211 Added 17.97%	296,832 $11.4 Million
Q2 2023 Aug 11, 2023	SELL	$14.2 - $23.75 $1.08 Million - $1.81 Million	-76,295 Reduced 23.27%	251,621 $4.77 Million
Q1 2023 May 11, 2023	BUY	$15.27 - $19.72 $1.49 Million - $1.92 Million	97,343 Added 42.22%	327,916 $5.09 Million
Q4 2022 Feb 13, 2023	BUY	$6.59 - $17.75 $1.52 Million - $4.09 Million	230,573 New	230,573 $4.09 Million
Q1 2022 May 13, 2022	SELL	$5.06 - $8.77 $961,025 - $1.67 Million	-189,926 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$7.33 - $9.32 $4,471 - $5,685	610 Added 0.32%	189,926 $1.62 Million
Q3 2021 Nov 10, 2021	SELL	$7.01 - $11.37 $125,289 - $203,216	-17,873 Reduced 8.63%	189,316 $1.65 Million
Q2 2021 Aug 10, 2021	BUY	$9.4 - $16.85 $104,255 - $186,883	11,091 Added 5.66%	207,189 $2.19 Million
Q1 2021 May 10, 2021	BUY	$13.08 - $49.6 $2.34 Million - $8.88 Million	179,130 Added 1055.69%	196,098 $3.15 Million
Q4 2020 Feb 10, 2021	SELL	$36.36 - $52.71 $166,056 - $240,726	-4,567 Reduced 21.21%	16,968 $784,000
Q3 2020 Nov 13, 2020	BUY	$22.61 - $38.9 $486,906 - $837,711	21,535 New	21,535 $758,000

Others Institutions Holding IMVT

# of Institutions

211

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Immunovant, Inc. Transaction History